Hydrogen sulfide epigenetically attenuates homocysteine-induced mitochondrial toxicity mediated through NMDA receptor in mouse brain endothelial (bEnd3) cells

Journal of Cellular Physiology

Volumn 230, Issue 2, 2015, Pages 378-394

  Kamat, Pradip K ^a   Kalani, Anuradha ^a   Tyagi, Suresh C ^a   Tyagi, Neetu ^a  

^a University of Louisville School of Medicine   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HOMOCYSTEINE; HYDROGEN SULFIDE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; REACTIVE OXYGEN METABOLITE;

ANIMAL; BRAIN; DRUG EFFECTS; ENDOTHELIUM CELL; GENETIC EPIGENESIS; HEART MITOCHONDRION; HYPERHOMOCYSTEINEMIA; METABOLISM; MITOCHONDRIAL MEMBRANE POTENTIAL; MITOCHONDRION; MOUSE; SIGNAL TRANSDUCTION;

ANIMALS; BRAIN; ENDOTHELIAL CELLS; EPIGENESIS, GENETIC; HOMOCYSTEINE; HYDROGEN SULFIDE; HYPERHOMOCYSTEINEMIA; MEMBRANE POTENTIAL, MITOCHONDRIAL; MICE; MITOCHONDRIA; MITOCHONDRIA, HEART; REACTIVE OXYGEN SPECIES; RECEPTORS, N-METHYL-D-ASPARTATE; SIGNAL TRANSDUCTION;

EID: 84911092432     PISSN: 00219541     EISSN: 10974652     Source Type: Journal    
DOI: 10.1002/jcp.24722     Document Type: Article

References (57)

1. Aslam M, Pfeil U, Gündüz D, Rafiq A, Kummer W, Piper HM, Noll T. 2011. Intermedin (adrenomedullin2) stabilizes the endothelial barrier and antagonizes thrombin-induced barrier failure in endothelial cell monolayers. Br J Pharmacol 165:208-222.
2. Austin RC, Lentz SR, Werstuck GH. 2004. Role of hyperhomocysteinemia in endothelial dysfunction and atherothrombotic disease. Cell Death Differ 11: S56-S64.
3. Baker MJ, Tatsuta T, Langer T. 2011. Quality control of mitochondrial proteostasis. Cold Spring Harb Perspect Biol 3.
4. Bazzoni G, Dejana E. 2004. Endothelial cell-to-cell junctions: Molecular organization and role in vascular homeostasis. Physiol Rev 84:869-901.
5. Chambers JC, McGregor A, Jean-Marie J, Obeid OA, Kooner JS. 1999. Demonstration of rapid onset vascular endothelial dysfunction after hyperhomocysteinemia: An effect reversible with vitamin C therapy. Circulation 99:1156-1160.
6. Chang PY, Lu SC, Lee CM, Chen YJ, Dugan TA, Huang WH, Chang SF, Liao WS, Chen CH, Lee YT. 2008. Homocysteine inhibits arterial endothelial cell growth through transcriptional downregulation of fibroblast growth factor-2 involving G protein and DNA methylation. Circ Res 102:933-941.
7. Chen CA, Wang TY, Varadharaj S, Reyes LA, Hemann C, Talukder MA, Chen YR, Druhan LJ, Zweier JL. 2010. S-Glutathionylation uncouples eNOS and regulates its cellular and vascular function. Nature 468:1115-1118.
8. Cirio MC, Martel J, Mann M, Toppings M, Bartolomei M, Trasler J, Chaillet JR. 2008. DNA methyltransferase 1o functions during preimplantation development to preclude a profound level of epigenetic variation. Dev Biol 324:139-150.
9. Dammanahalli KJ, Sun Z. 2008. Endothelins and NADPH oxidases in the cardiovascular system. Clin Exp Pharmacol Physiol 35:2-6.
10. Doronzo G, Russo I, Del Mese P, Viretto M, Mattiello L, Trovati M, Anfossi G. 2009. Role of NMDA receptor in homocysteine-induced activation of mitogen-activated protein kinase and phosphatidyl inositol 3-kinase pathways in cultured human vascular smooth muscle cells. Thromb Res 125:e23-e32.
11. Duchen MR. 2004. Roles of mitochondria in health and disease. Diabetes 53:S96-S102.
12. Eberhardt RT, Forgione MA, Cap A, Leopold JA, Rudd MA, Trolliet M, Heydrick S, Stark R, Klings ES, Moldovan NI, Yaghoubi M, Goldschmidt-Clermont PJ, Farber HW, Cohen R, Loscalzo J. 2000a. Endothelial dysfunction in a murine model of mild hyperhomocyst(e) inemia. J Clin Invest 106:483-491.
13. Eberhardt W, Huwiler A, Beck KF, Walpen S, Pfeilschifter J. 2000. Amplification of IL-1 beta-induced matrix metalloproteinase-9 expression by superoxide in rat glomerular mesangial cells is mediated by increased activities of NF-kappa B and activating protein-1 and involves activation of the mitogen-activated protein kinase pathways. J Immunol 165:5788-5797.
14. Edirimanne VE, Woo CW, Siow YL, Pierce GN, Xie JY, O K. 2007. Homocysteine stimulates NADPH oxidase-mediated superoxide production leading to endothelial dysfunction in rats. Can J Physiol Pharmacol 85:1236-1247.
15. Faraci FM, Lentz SR. 2004. Hyperhomocysteinemia, oxidative stress, and cerebral vascular dysfunction. Stroke 35:345-347.
16. Girouard H, Wang G, Gallo EF, Anrather J, Zhou P, Pickel VM, Iadecola C. 2009. NMDA receptor activation increases free radical production through nitric oxide and NOX2. J Neurosci 29:2545-2552.
17. Green LC, Wagner DA, Glogowski J, Skipper PL, Wishnok JS, Tannenbaum SR. 1982. Analysis of nitrate, nitrite, and [15N] nitrate in biological fluids. Anal Biochem 126:131-138.
18. Grynkiewicz G, Poenie M, Tsien RY. 1985. A new generation of Ca2+ indicators with greatly improved fluorescence properties. J Biol Chem 260:3440-3450.
19. Iglarz M, Clozel M. 2007. Mechanisms of ET-1-induced endothelial dysfunction. J Cardiovasc Pharmacol 50:621-628.
20. Johansen T, Lamark T. 2011. Selective autophagy mediated by autophagic adapter proteins. Autophagy 7:279-296.
21. Kalani A, Kamat PK, Givvimani S, Brown K, Metreveli N, Tyagi SC, et al. 2013. Nutri-epigenetics ameliorates blood-brain barrier damage and neurodegeneration in hyperhomocysteinemia: Role of folic acid. J Mol Neurosci 13:0122-0125.
22. Kamat PK, Tota S, Shukla R, Ali S, Najmi AK, Nath C. 2011. Mitochondrial dysfunction: A crucial event in okadaic acid (ICV) induced memory impairment and apoptotic cell death in rat brain. Pharmacol Biochem Behav 100:311-319.
23. Kamat PK, Kalani A, Givvimani S, Sathnur PB, Tyagi SC, Tyagi N. 2013. Hydrogen sulfide attenuates neurodegeneration and neurovascular dysfunction induced by intracerebral-administered homocysteine in mice. Neuroscience 252:302-319.
24. Kimura H. 2011. Hydrogen sulfide: Its production, release and functions. Amino Acids 41:113-121.
25. Levonen AL, Lapatto R, Saksela M, Raivio KO. 2000. Human cystathionine gamma-lyase: Developmental and in vitro expression of two isoforms. Biochem J 1:291-295.
26. Lipton SA. 2004. Paradigm shift in NMDA receptor antagonist drug development: Molecular mechanism of uncompetitive inhibition by memantine in the treatment of Alzheimer's disease and other neurologic disorders. J Alzheimers Dis 6:S61-S74.
27. Lominadze D, Tyagi N, Sen U, Ovechkin A, Tyagi SC. 2012. Homocysteine alters cerebral microvascular integrity and causes remodeling by antagonizing GABA-A receptor. Mol Cell Biochem 371:89-96.
28. Low HQ, Chen CP, Kasiman K, Thalamuthu A, Ng SS, Foo JN, et al. 2012. A comprehensive association analysis of homocysteine metabolic pathway genes in Singaporean Chinese with ischemic stroke. PLoS ONE 6:e24757.
29. Lowicka E, Beltowski J. 2007. Hydrogen sulfide (H2S)-The third gas of interest for pharmacologists. Pharmacol Rep 59:4-24.
30. Lu Y, Rosenberg PA. 2007. NMDA receptor-mediated extracellular adenosine accumulation is blocked by phosphatase 1/2A inhibitors. Brain Res 1155:116-124.
31. Luo C, Li Y, Wang H, Feng Z, Li Y, Long J, Liu J. 2013. Mitochondrial accumulation under oxidative stress is due to defects in autophagy. J Cell Biochem 114:212-219.
32. Moscat J, Diaz-Meco MT. 2009. p62 at the crossroads of autophagy, apoptosis, and cancer. Cell 137:1001-1004.
33. Moshal KS, Tipparaju SM, Vacek TP, Kumar M, Singh M, Frank IE, Patibandla PK, Tyagi N, Rai J, Metreveli N, Rodriguez WE, Tseng MT, Tyagi SC. 2008. Mitochondrial matrix metalloproteinase activation decreases myocyte contractility in hyperhomocysteinemia. Am J Physiol Heart Circ Physiol 295:H890-H897.
34. Moshal KS, Kumar M, Tyagi N, Mishra PK, Metreveli N, Rodriguez WE, Tyagi SC. 2009. Restoration of contractility in hyperhomocysteinemia by cardiac-specific deletion of NMDA-R1. Am J Physiol Heart Circ Physiol 296:H887-H892.
35. Nicholls DG, Johnson-Cadwell L, Vesce S, Jekabsons M, Yadava N. 2007. Bioenergetics of mitochondria in cultured neurons and their role in glutamate excitotoxicity. J Neurosci Res 85:3206-3212.
36. Obeid R, Herrmann W. 2006. Mechanisms of homocysteine neurotoxicity in neurodegenerative diseases with special reference to dementia. FEBS Lett 580:2994-3005.
37. Petrosillo G, Ruggiero FM, Pistolese M, Paradies G. 2004. Ca2+-induced reactive oxygen species production promotes cytochrome c release from rat liver mitochondria via mitochondrial permeability transition (MPT)-dependent and MPT-independent mechanisms: Role of cardiolipin. J Biol Chem 279:53103-53108.
38. Poddar R, Paul S. 2009. Homocysteine-NMDA receptor-mediated activation of extracellular signal-regulated kinase leads to neuronal cell death. J Neurochem 110:1095-1106.
39. Rai S, Kamat PK, Nath C, Shukla R. 2013. A study on neuroinflammation and NMDA receptor function in STZ (ICV) induced memory impaired rats. J Neuroimmunol 254:1-9.
40. Reinhart B, Chaillet JR. 2005. Genomic imprinting: Cis-acting sequences and regional control. Int Rev Cytol 243:173-213.
41. Santos-Reboucas CB, Pimentel MM. 2007. Implication of abnormal epigenetic patterns for human diseases. Eur J Hum Genet 15:10-17.
42. Sas K, Robotka H, Toldi J, Vecsei L. 2007. Mitochondria, metabolic disturbances, oxidative stress and the kynurenine system, with focus on neurodegenerative disorders. J Neurol Sci 257:221-239.
43. Shen WD, Ji Y, Liu PF, Xiang B, Chen GQ, Huang B, Wu S. 2011. Correlation of E-cadherin and CD44v6 expression with clinical pathology in esophageal carcinoma. Mol Med Rep 5:817-821.
44. Shigenaga MK, Hagen TM, Ames BN. 1994. Oxidative damage and mitochondrial decay in aging. Proc Natl Acad Sci USA 91:10771-10778.
45. Swarnkar S, Goswami P, Kamat PK, Gupta S, Patro IK, Singh S, Nath C. 2012. Rotenone-induced apoptosis and role of calcium: A study on Neuro-2a cells. Arch Toxicol 86:1387-1397.
46. Tyagi N, Gillespie W, Vacek JC, Sen U, Tyagi SC, Lominadze D. 2009a. Activation of GABA-A receptor ameliorates homocysteine-induced MMP-9 activation by ERK pathway. J Cell Physiol 220:257-266.
47. Tyagi N, Givvimani S, Qipshidze N, Kundu S, Kapoor S, Vacek JC, Tyagi SC. 2010. Hydrogen sulfide mitigates matrix metalloproteinase-9 activity and neurovascular permeability in hyperhomocysteinemic mice. Neurochem Int 56:301-307.
48. Tyagi N, Mishra PK, Tyagi SC. 2009b. Homocysteine, hydrogen sulfide (H2S) and NMDA-receptor in heart failure. Indian J Biochem Biophys 46:441-446.
49. Tyagi N, Ovechkin AV, Lominadze D, Moshal KS, Tyagi SC. 2006. Mitochondrial mechanism of microvascular endothelial cells apoptosis in hyperhomocysteinemia. J Cell Biochem 98:1150-1162.
50. Tyagi N, Sedoris KC, Steed M, Ovechkin AV, Moshal KS, Tyagi SC. 2005. Mechanisms of homocysteine-induced oxidative stress. Am J Physiol Heart Circ Physiol 289:H2649-H2656.
51. Vazquez CL, Colombo MI. 2009. Assays to assess autophagy induction and fusion of autophagic vacuoles with a degradative compartment, using monodansylcadaverine (MDC) and DQ-BSA. Methods Enzymol 452:85-95.
52. Weiss N, Miller F, Cazaubon S, Couraud PO. 2009. The blood-brain barrier in brain homeostasis and neurological diseases. Biochim Biophys Acta 1788:842-857.
53. White JE, Tsan MF. 2001. Differential induction of TNF-alpha and MnSOD by endotoxin: Role of reactive oxygen species and NADPH oxidase. Am J Respir Cell Mol Biol 24:164-169.
54. Wilson AS, Power BE, Molloy PL. 2007. DNA hypomethylation and human diseases. Biochim Biophys Acta 1775:138-162.
55. Zeevalk GD, Bernard LP, Sinha C, Ehrhart J, Nicklas WJ. 1998. Excitotoxicity and oxidative stress during inhibition of energy metabolism. Dev Neurosci 20:444-453.
56. Zhang J, Kundu M, Ney PA. 2009. Mitophagy in mammalian cells: The reticulocyte model. Methods Enzymol 452:227-245.
57. Zhen P, Zhao Q, Hou D, Liu T, Jiang D, Duan J, Lu L, Wang W. 2012. Genistein attenuates vascular endothelial impairment in ovariectomized hyperhomocysteinemic rats. J Biomed Biotechnol 2012:730462.